Pharma Trust Index™
The Moody's for GMP Compliance.
The Pharma Trust Index (PTI) is the world’s only independent benchmark for pharmaceutical GMP compliance, helping insurers, manufacturers, regulators, and investors manage risk with confidence.
Want to Join our Pilot Scheme?
Pharmalliance has opened a limited pilot for insurers and reinsurers. Gain early access to Pharma Trust Index (PTI) scoring, shape underwriting models, and secure first-mover advantage in pharma risk pricing.
Register below and get your instant confidential briefing pack today.
The Pharma Trust Index™ (PTI) is a proprietary benchmark developed by Pharmalliance Consulting Ltd and protected under international IP and trade secret laws.
Who Is The Pharma Trust Index (PTI) For?
The Pharma Trust Index has been designed to provide invaluable insights:
For Insurers
Price pharmaceutical risk with confidence. PTI links GMP compliance to underwriting, reducing uncertainty and enabling fair premiums.
For Manufacturers
Boost credibility and lower premiums. PTI ratings prove compliance maturity, rewarding strong GMP systems and faster recovery after issues.
For Regulators
Benchmark GMP compliance consistently. PTI highlights high-risk sites, supports oversight prioritisation, and strengthens patient protection.
For Investors
Protect capital and supply chains. PTI ratings provide early signals of GMP weakness, reducing investment risk and ensuring reliability.
How it Works
Inspection Outcome
Anchored on official GMP inspection results, providing a trusted baseline of compliance strength.
Risk Memory
Accounts for both active enforcement actions and recovery periods, aligning with insurance risk horizons.
Regulatory Signals
The PTI integrates FDA warning letters, recalls, and global enforcement actions to capture real-world compliance risk.
Single Score
Converts complex compliance data into one clear PTI Score (0–100), mapped to an AAA–C rating scale as per financial credit models.
Global Coverage
Draws on FDA, EMA, MHRA, TGA and other regulator data to ensure consistent, international benchmarking.
Comparability
Enables instant cross-company, cross-site comparisons, making compliance risk visible at a glance both internally and externally.
Customer Benefits
Reduced Uncertainty
Insurers gain clearer insight into GMP risk, supporting more accurate and confident underwriting.
Investor Assurance
Investors can quickly assess the reliability of pharma partners, reducing exposure to compliance shocks.
Fairer Premiums
Strongly compliant manufacturers are rewarded with improved PTI ratings and potential insurance savings.
Regulatory Alignment
Supports global regulators by highlighting high-risk sites and improving global consistency in quality oversight.
Early Warnings
PTI highlights emerging compliance risks before regulators act, protecting supply chains and patients.
Market Advantage
Investors gain invaluable insights using our proprietary PIT score for risk management and investment decisions.